Haidong Bu | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Mr. Haidong Bu | Molecular Biology | Best Researcher Award

Mr. Haidong Bu at Mudanjiang Branch of Heilongjiang Academy of Agricultural Sciences, China

Dr. Haidong Bu is an Associate Researcher at the Mudanjiang Branch of the Heilongjiang Academy of Agricultural Sciences with 15 years of experience in horticultural research. He specializes in apple breeding, fruit quality improvement, and plant molecular biology. He has published 75 research papers, including 13 SCI-indexed articles, and contributed to 15 books. Dr. Bu has also led numerous national and provincial research projects and holds multiple patents in fruit tree cultivation. As an expert in horticultural science, he plays a vital role in advancing apple breeding technologies and is actively involved in academic and industry collaborations. 🍏📚

Publication Profile

Orcid

Academic Background🎓

Dr. Haidong Bu holds a Ph.D. in Pomology from Shenyang Agricultural University (2016–2021) and completed postdoctoral research in Horticulture at Heilongjiang Academy of Agricultural Sciences (2022–2024). He earned an M.S. in Pomology (2007–2010) and a B.S. in Horticulture (2003–2007) from Jilin Agricultural University. His academic journey has been dedicated to fruit tree breeding and molecular biology, contributing significantly to apple and pear research. His studies focus on fruit size regulation, stress resistance, and genetic improvement, shaping advancements in the horticultural industry. 🌱🍏

Professional Background🏅

Dr. Haidong Bu has been an Associate Researcher at the Heilongjiang Academy of Agricultural Sciences since 2021, after serving as an Assistant Researcher (2012–2019) and Research Intern (2010–2012). He has also been a Master’s Supervisor at Shenyang Agricultural University since 2018. His expertise in apple breeding and fruit quality improvement has led to significant contributions to cold-region fruit cultivation. With extensive experience in molecular research, he has developed innovative orchard management techniques and disease-resistant fruit varieties, influencing both academia and industry through his leadership and technical expertise. 🌿🧬

Awards and Honors🏆

Dr. Haidong Bu has received multiple prestigious awards, including the Heilongjiang Agricultural Science and Technology Award (Second Prize, 2016) and the Heilongjiang Science and Technology Award (Third Prize, 2017). He was honored as an “Outstanding Individual” by the Heilongjiang Academy of Agricultural Sciences (2021, 2022, 2024) and won First Prize in its Thesis Competition (2021). His research team also earned recognition for excellence (2020–2021, 2024). He was awarded the “Agricultural Science Outstanding Youth” (2022) and the “Young Seedling Award” (2023), acknowledging his contributions to fruit tree research. 🏅🍎

Research Focus🔬

Dr. Haidong Bu’s research focuses on apple and pear breeding, fruit size regulation, stress resistance, and molecular mechanisms influencing fruit development. His work involves gene expression studies related to auxin, ethylene, and histone modifications, contributing to fruit quality improvement. He also explores innovative orchard management techniques, disease-resistant cultivars, and IoT-based monitoring systems for sustainable fruit production. His expertise extends to selenium biofortification, apple disease prevention, and optimizing cold-region fruit cultivation strategies, making a significant impact on horticultural science and agricultural productivity. 🌳🍐

Publication Top Notes

1️⃣ The MdAux/IAA2 Transcription Repressor Regulates Cell and Fruit Size in Apple Fruit 🏵️📖
Year: 2022

2️⃣ Auxin‐activated MdARF5 Induces the Expression of Ethylene Biosynthetic Genes to Initiate Apple Fruit Ripening 🍎🧬
Year: 2020

3️⃣ Histone Acetylation at the Promoter for the Transcription Factor PuWRKY31 Affects Sucrose Accumulation in Pear Fruit 🍐📊
Year: 2020

Conclusion

Haidong Bu is an accomplished researcher in agricultural sciences, specializing in pomology and horticulture, with over 15 years of experience at the Heilongjiang Academy of Agricultural Sciences. He has made significant contributions through 75 research papers (including 13 SCI-indexed), 15 authored books, multiple patents, and the registration of new apple varieties. As an Associate Researcher and Master’s Supervisor, he has led and participated in numerous national and provincial research projects. His outstanding achievements have earned him prestigious awards like the Heilongjiang Science and Technology Award and the Agricultural Science Outstanding Youth Award, making him a strong contender for the Best Researcher Award.

 

 

Mai O. Kadry | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Publication Profile

Scopus

Academic and Professional Experience 🌟🎓

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

 

Educational Background 🎓📘

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

 

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

 

Research Focus 🧪🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports 🧪
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology 💊
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports 🔬 (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA 🧪 (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA 🎗️ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery 🚑